Contact this trialFirst, we need to learn more about you.
IDH1 Inhibitor
Targeted Therapies for Acute Myeloid Leukemia
Recruiting1 awardPhase 1 & 2
Los Angeles, California
This trial will screen for a specific type of leukemia and assign patients to different sub-studies based on their subtype. The goal is to find new, targeted therapies for different subtypes of the disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.